Skip to main content

Boehringer Ingelheim to Use Genomatix Software

NEW YORK (GenomeWeb News) – Genomatix said today that Boehringer Ingelheim has installed one of its Mining Stations (GMS) and one of its Genome Analyzers (GGA) at its Pharma Research Center in Biberach, Germany.

The company said the two systems combine hardware, databases, and software for next-generation sequencing studies.

The GMS provides mapping of sequencing of any length, "with no practical limits on the number of point mutations, insertions, or deletions," and it can be used for SNP detection and genotyping, copy number analysis, and small RNA analysis. The package includes a GenomeThesaurus for splice junction analysis and identifying new transcriptional units.

The GGA is used to perform a number of deep biological analysis functions on data coming from the GMS, and it annotates genomic coordinates and surrounding areas derived using the GMS or other mapping procedures.

Financial terms of the agreement were not released.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.